Investment House LLC Reduces Position in Kenvue Inc. $KVUE

Investment House LLC decreased its holdings in Kenvue Inc. (NYSE:KVUE) by 75.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,084 shares of the company’s stock after selling 93,597 shares during the quarter. Investment House LLC’s holdings in Kenvue were worth $488,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of KVUE. Vanguard Group Inc. raised its holdings in shares of Kenvue by 1.8% during the second quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock valued at $4,881,844,000 after purchasing an additional 4,101,880 shares during the last quarter. Geode Capital Management LLC grew its position in Kenvue by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 49,001,887 shares of the company’s stock worth $1,021,267,000 after purchasing an additional 604,953 shares during the period. Independent Franchise Partners LLP grew its position in Kenvue by 233.4% in the 2nd quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock worth $654,388,000 after purchasing an additional 21,886,537 shares during the period. American Century Companies Inc. raised its stake in Kenvue by 38.6% during the 2nd quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock valued at $633,447,000 after buying an additional 8,436,166 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Kenvue during the 2nd quarter valued at $537,418,000. Institutional investors own 97.64% of the company’s stock.

Insider Buying and Selling at Kenvue

In other news, Director Jeffrey C. Smith bought 3,200,000 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were bought at an average price of $17.37 per share, for a total transaction of $55,584,000.00. Following the purchase, the director owned 27,307,632 shares in the company, valued at $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Company insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the company. Canaccord Genuity Group reaffirmed a “hold” rating and issued a $15.00 price objective (down previously from $26.00) on shares of Kenvue in a report on Wednesday, October 29th. JPMorgan Chase & Co. dropped their target price on Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research report on Friday, October 10th. Jefferies Financial Group cut their price target on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a research note on Monday, October 27th. Bank of America lowered their price objective on shares of Kenvue from $25.00 to $21.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, Zacks Research raised shares of Kenvue from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $20.23.

Kenvue Stock Up 0.4%

KVUE stock opened at $17.82 on Monday. The business’s 50-day moving average price is $17.05 and its 200-day moving average price is $18.13. The stock has a market cap of $34.14 billion, a P/E ratio of 23.76 and a beta of 0.60. The company has a quick ratio of 0.69, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a twelve month low of $14.02 and a twelve month high of $25.17.

Kenvue (NYSE:KVUE) last released its earnings results on Monday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The company had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.83 billion. During the same period in the prior year, the firm posted $0.28 EPS. The firm’s quarterly revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.7%. The ex-dividend date was Wednesday, November 12th. Kenvue’s dividend payout ratio (DPR) is presently 110.67%.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.